Skip to main content

Main menu

  • Home
  • About the Journal
    • General Information
    • Scope
    • Editorial Board
    • Benefits of Publishing
    • Impact & Metrics
    • Advertising/Sponsorship
    • About the Biochemical Society
  • Current Issue
  • For Authors
    • Submit Your Paper
    • Submission Guidelines
    • Editorial Policy
    • Open Access Policy
    • Rights and Permissions
    • Biochemical Society Member Benefits
  • For Librarians
    • Open Access Policy
    • Terms and Conditions
      • Biochemical Journal- Terms and Conditions of Usage
      • Bioscience Reports- Terms and Conditions of Usage
  • For Readers
    • Rights and Permissions
    • Biochemical Society Member Benefits
  • Collections
  • Help
    • Technical Support
    • Contact Us
  • Other Publications
    • Biochemical Journal
    • Clinical Science
    • Bioscience Reports
    • Neuronal Signaling
    • Biochemical Society Transactions
    • Essays in Biochemistry
    • Emerging Topics in Life Sciences
    • Biochemical Society Symposia
    • Cell Signalling Biology
    • Glossary of Biochemistry and Molecular Biology
    • The Biochemist
    • Biochemical Society

User menu

  • Log-in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • Other Publications
    • Biochemical Journal
    • Clinical Science
    • Bioscience Reports
    • Neuronal Signaling
    • Biochemical Society Transactions
    • Essays in Biochemistry
    • Emerging Topics in Life Sciences
    • Biochemical Society Symposia
    • Cell Signalling Biology
    • Glossary of Biochemistry and Molecular Biology
    • The Biochemist
    • Biochemical Society

Log-in

Sign-up for alerts  
  • My Cart
Bioscience Reports
Browse Archive
Advanced Search
  • Home
  • About the Journal
    • General Information
    • Scope
    • Editorial Board
    • Benefits of Publishing
    • Impact & Metrics
    • Advertising/Sponsorship
    • About the Biochemical Society
  • Current Issue
  • For Authors
    • Submit Your Paper
    • Submission Guidelines
    • Editorial Policy
    • Open Access Policy
    • Rights and Permissions
    • Biochemical Society Member Benefits
  • For Librarians
    • Open Access Policy
    • Terms and Conditions
  • For Readers
    • Rights and Permissions
    • Biochemical Society Member Benefits
  • Collections
  • Help
    • Technical Support
    • Contact Us

Research Article

Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case–control studies

Huanhuan Guo, Tao Peng, Ping Luo, Huabin Li, Shuo Huang, Shuang Li, Weidong Zhao, Xuhong Zhou
Bioscience Reports Jul 31, 2018, 38 (4) BSR20180177; DOI: 10.1042/BSR20180177
Huanhuan Guo
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
Tao Peng
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
Ping Luo
Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
Huabin Li
Department of Otolaryngology, Head and Neck Surgery, Affiliated Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
Shuo Huang
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
Shuang Li
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
Weidong Zhao
Department of Otolaryngology, Head and Neck Surgery, Affiliated Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
  • For correspondence: zhouxuhong62@126.comzhaowda@sina.com
Xuhong Zhou
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • View author's works on this site
  • For correspondence: zhouxuhong62@126.comzhaowda@sina.com
  • Article
  • Figures
  • Info & Metrics
  • PDF
Loading

Abstract

Purpose: Accumulating evidence has shown that allergic diseases are caused by a complex interaction of genetic and environmental factors, some single nucleotide polymorphisms (SNPs) existing in high-affinity IgE receptor β chain (FcεRIβ) are potential risk factors for allergic diseases. However, the results have been inconsistent and inconclusive due to the limited statistical power in individual study. Thus, we conducted a meta-analysis to systematically evaluate the association between FcεRIβ SNPs and allergic diseases risk.

Methods: Eligible studies were collected from PubMed, Embase, Web of Science, Chinese National Knowledge Infrastructure, and WanFang databases. Pooled odd ratios (ORs) and corresponding 95% confidence intervals (95% CIs) were calculated to assess the strength of the relationships between five polymorphisms (E237G, -109 C/T, RsaI_in2, RsaI_ex7, and I181L) and the risk of allergic diseases by using five genetic models. In addition, the stability of our analysis was evaluated by publication bias, sensitivity, and heterogeneity analysis.

Results: Overall, a total of 29 case–control studies were included in this meta-analysis. We found that E237G (B vs. A: OR = 1.28, 95% CI = 1.06–1.53, P<0.001, I2 = 63.1%) and -109 C/T (BB vs. AA + AB: OR = 1.58, 95%CI = 1.26–1.98, P<0.001, I2 = 66.4%) were risk factors for allergic diseases.

Conclusion: Our meta-analysis suggests that polymorphisms in FcεRIβ may be associated with the development of allergic diseases.

  • allergic diseases
  • genetic model
  • FcεRIβ
  • Meta-analysis
  • polymorphism

Introduction

Allergic rhinitis (AR) is a common nasal mucosal inflammation, approximately 10–20% of the global population suffers from AR, and the classic symptoms of AR are nasal congestion, nasal itching, sneezing, and rhinorrhea. Allergic conjunctivitis presents as itchy, watery eyes resulting from the same pathophysiology as AR and is not surprisingly a common comorbid condition.

As an allergen-mediated disorder of the nasal passage, AR shares several similarities with another allergic disease of the lower respiratory tract: asthma. Not surprisingly, the two conditions are often comorbid; 85% of patients with asthma have AR whereas 40% of patients suffering from AR have or will develop asthma [1]. As a type 1 immunoglobulin (Ig)E-mediated hypersensitivity process, symptoms of them are triggered by allergens. The reported prevalence of allergic diseases has been steadily increasing. The true incidence probably remains underestimated. Asthma, one of the most common chronic respiratory diseases of childhood, is characterized by recurrent respiratory symptoms, reversible variable airway obstruction, airway inflammation, and increased bronchial hyper-responsiveness [2–4]. Its incidence is on the rise among children, which brings heavy burden to the whole society and results in huge medical expenditure around the world. It is thought to be caused by a combination of genetic and environmental factors [5,6].

AR and asthma are complex multifactorial disorders, with both genetic and environmental components determining disease expression, show strong familial aggregation and heritability [7,8], thus suggesting that genetic risk factors may underlie the risk of developing, or the clinical presentation of, allergic diseases [9–11]. Allergic diseases are also associated with elevated serum IgE levels and increased mediator release from activated inflammatory cells. Allergens cross-link IgE bound to FcεRIα that causes FcεRI clustering and activates the receptor complexes (FcεRIα, FcεRIβ, and FcεRIγ-γ homodimer) on the surface of mast cells or basophils, releasing vasoactive mediators, such as histamine. Although the search for genetic susceptibility factors related to allergic diseases is a promising field, gene variations related to FcεRI as potential risk factors for allergic diseases have not been comprehensively analyzed, and the results available are in some cases contradictory, some studies showed the variant of Glu237Gly of FcεRIβ gene showed association with atopic diseases and the variant is also associated with very high total serum IgE levels [12–19], but others were showed no association with atopic asthma [20–22].

FcεRI has a tetrameric structure consisting of three distinct polypeptides including the IgE-binding α chain, 4-fold membrane-spanning β chain, and disulfide-linked γ–γ homodimer [23]. The β chain of the FcεRI is found on mast cells and basophils, and acts as a signal amplifier in mast cell activation [24–26]. Cross-linking of this receptor leads to increased IL-4 production by these cells. The aggregation of FcεRI by the bounding of IgE with multivalent antigens has been shown to induce the release of histamine, leukotrienes, and inflammatory cytokines, and plays an important role in allergic inflammation [27,28]. Furthermore, the β chain was previously reported to amplify early activation signals 5–7-fold through FcεRI in humans [25]. The β chain has also been suggested to function as a stabilizer of the FcεRI complex [29]. It contains an immunoreceptor tyrosine-based activation motif, a conserved feature of many antigen receptors that imparts signaling competence. The FcεRI β chain acts as a signal amplifier through the immunoreceptor tyrosine-based activation motif in its C-terminal intracellular region. Mutations in the FCERIB gene could alter IL-4 production and thus modify IgE levels.

Several studies on the genetic background of atopy likely to contribute to the pathogenesis of allergies [30–33], of these, a significant role for polymorphisms in the FcεRI β chain in the manifestation of the phenotype has been suggested. Genetic linkage studies demonstrated that a locus in chromosome 11q13 [34] encompassing the β chain gene was linked to various allergic disorders and high levels of serum IgE [35–37]. Polymorphisms in FcεRIβ have been linked to atopy, asthma, and allergies. This meta-analysis comprehensively discussed the association between the FcεRIβ polymorphisms and allergic diseases risk.

Materials and methods

Strategy for literature search

The electronic databases of PubMed, Embase, Web of science, Chinese National Knowledge Infrastructure (CNKI), and WanFang database were comprehensively searched to retrieve relevant articles published between January 2000 and August 2017. Databases were searched using the search term: “bronchial asthma, asthma, allergic rhinitis, nasal allergy, allergic diseases”, “Fc epsilon RI beta, FcεRIβ, high-affinity IgE receptor beta chain, beta-subunit of the high-affinity receptor for IgE”, “single nucleotide polymorphism, SNP, polymorphism, polymorphisms” as well as their combinations were employed as the searching keywords. The corresponding Chinese version was used in the Chinese databases. To obtain more data, we manually searched the references of related articles. Our analysis only focused on the studies that were written in English and Chinese. When the same authors or laboratories reported this issue on the same population, only the latest published full-text article was included.

Inclusion and exclusion criteria

The following criteria were set to choose the studies included in the current meta-analysis: (1) case–control design; (2) the study must offer the sample size, distribution of alleles, genotypes, or other information that can help us infer the results; and (3) the publication on the association between polymorphisms of FcεRIβ and risk of asthma and/or allergic rhinitis. The exclusion criterions were as follows: (1) review articles, case reports, and meta-analysis; (2) the studies were conducted on animals; (3) genotype distribution data were unavailable; and (4) when multiple publications reported on the same or overlapping data, we used the most recent or largest population.

Data extraction

Data were carefully extracted independently by two authors (Huan-huan Guo and Ping Luo) according to the inclusion and exclusion criteria. Disagreements were resolved through discussion and arbitration by a third author if necessary. For each study, the following data were recorded: first author, year of publication, country, age, allergic status, number of cases and controls, and genotype distributions in cases and controls.

Quality assessment

The quality of studies was independently assessed by the two reviewers using the Newcastle–Ottawa scale (NOS) [38] based on three aspects: selection, comparability, and exposure of cases and controls. NOS scores ranged from 0 to 9, and articles with a score equal to or higher than six were regarded as high quality.

Statistical analysis

Hardy–Weinberg equilibrium (HWE) for the genotype distribution of FcεRIβ in controls was tested by χ2 analysis with exact probability. The pooled odd ratio (OR) with 95% confidence interval (CI) was used to assess the strength of the associations between the genetic variants and allergic diseases risk. For the FcεRIβ polymorphism, “A” stands for wild-type gene, and “B” for mutant gene, the allelic (B vs. A), heterozygous (AB vs. AA), homozygous (BB vs. AA), dominant (AB+BB vs. AA), and recessive (BB vs. AA+AB) genetic models were used to obtain pooled ORs. The evaluated genetic models for each study were based mostly on those used in primary studies. Heterogeneity assumption was evaluated by a X2 based Q test and I2 test [39]. A significant Q test (P<0.10) indicated heterogeneity across studies. I2 was used to measure the percentage of variability in point estimated that due to heterogeneity rather than sampling error. When there was no statistical heterogeneity, we used a fixed effects model (the Mantel–Haenszel method) [40], otherwise, a random effects model (DerSimonian and Laird method) was used [41]. The subgroup analysis was performed according to ethnicity, allergic status, and HWE status of controls. Begg rank correlation method and the Egger linear regression method were used to assess potential publication bias [42,43]. The meta-analysis was performed using STATA Version 12.0 (Stata Corp, College Station, TX, U.S.A.) software. P value less than 0.05 was considered statistically significant. All P values presented are two-tailed.

Results

Main characteristics of the selected studies

Figure 1 outlined the study process of selection. Briefly, we first identified 234 articles. After applying the inclusion and exclusion criteria, a total of 29 articles including 6496 allergic diseases patients and 5828 controls were screened out. Of the 29 articles, 9 were written in Chinese [22,44–51] and 20 in English [13–21,52–62]. Among them, 22 were conducted in Asian populations and 7 in Caucasian populations. The FcεRIβ polymorphism was measured by seven different methods (ARMS-PCR, PCR-SSCP, PCR-RFLP, SNP-IT™, ABI, MALDI-TOF, and TaqMan). Within the genotype distribution in the controls, the value of HWE was either extracted in the articles directly or calculated using the data of controls. Only three studies deviated from HWE [52,60,49]. Table 1 listed the main characteristics of included studies. Table 2 exhibited the distribution information of alleles and genotypes of FcεRIβ polymorphism.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1 Flow chart of selection process in this meta-analysis
View this table:
  • View inline
  • View popup
Table 1 Main characteristics of included studies in this meta-analysis
View this table:
  • View inline
  • View popup
Table 2 Summary ORs and 95% CIs of FcεRIβ polymorphisms and allergic diseases risk

Association of E237G and -109C/T polymorphisms in asthma and/or allergic rhinitis risk

Twenty-five case–control studies involving the E237G polymorphism with 10,084 individuals (5081 cases and 5003 controls) were included in this meta-analysis. The overall results suggested that the allelic model of E237G polymorphism had an increased the risk of the allergic diseases (B vs. A: OR = 1.28, 95% CI = 1.06–1.53, P<0.001, I2 = 63.1%, Figure 2). No significant association was revealed in the pooled results under other genetic model statistically. For subgroup analysis based on the ethnicity, significantly increased risk were observed in Asian population for allelic model (B vs. A: OR = 1.23, 95% CI = 1.05–1.45, P=0.004, I2 = 53.6%, Figure 3) and recessive genetic model (BB vs. AA + AB: OR = 2.10, 95% CI = 1.22–3.62, P<0.001, I2 = 68.8%). In allergic status subgroup analysis, we also observed increased risk of asthma for allelic model (B vs. A: OR = 1.25, 95% CI = 1.04–1.51, P<0.001, I2 = 60.5%, Figure 4) and recessive genetic model (BB vs. AA + AB: OR = 2.09, 95% CI = 1.19–3.65, P<0.001, I2 = 67.7%). For subgroup analysis based on source of controls and HWE status of controls, a significant association was found (B vs. A: HWE ≥ 0.05, OR = 1.33, 95% CI = 1.08–1.63, P<0.001, I2 = 65%, Figure 5). Table 2 presented the detailed results of the meta-analysis.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2 ORs and 95% CIs for the associations between E237G polymorphism and allergic diseases risk in allelic genetic model for overall populations
Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3 ORs and 95% CIs for the associations between E237G polymorphism and allergic diseases risk in allelic genetic model by ethnicity
Figure 4
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4 ORs and 95% CIs for the associations between E237G polymorphism and allergic diseases risk in allelic genetic model by allergic status
Figure 5
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5 ORs and 95% CIs for the associations between E237G polymorphism and allergic diseases risk in allelic genetic model by HWE

A total of 15 eligible studies, consisting of 3909 cases and 4145 controls focused on -109 C/T polymorphisms. The overall OR with its 95% CI revealed a significantly increased risk of allergic diseases in recessive genetic model (BB vs. AA + AB: OR = 1.58, 95% CI = 1.26–1.98, P<0.001, I2 = 66.4%). No significant association was revealed in the other genetic models. In recessive genetic model, significant increased risk was found in all the three subgroup analysis by ethnicity (BB vs. AA + AB: Caucasian, OR = 1.50, 95% CI = 1.18–1.92, P=0.866, I2 = 0%; Asian, OR = 1.60, 95% CI = 1.19–2.14, P<0.001, I2 = 71.6%), allergic status (BB vs. AA + AB: asthma, OR = 1.58, 95% CI = 1.20–2.08, P<0.001, I2 = 69.6%; allergic rhinitis, OR = 1.65, 95% CI = 1.07–2.55; OR = 1.46, 95% CI = 1.05–2.02), and HWE (BB vs. AA + AB: HWE ≥ 0.05, OR = 1.54, 95% CI = 1.19–1.99, P<0.001, I2 = 72.2%; HWE < 0.05, OR = 1.80, 95% CI = 1.10–2.92, P=0.349, I2 = 5.1%) respectively.

Table 3 summarized the association between the clinical characteristics and the polymorphisms of E237G and -109C/T, including the gender, age, positive RAST, and total serum IgE level.

View this table:
  • View inline
  • View popup
Table 3 Clinical characteristics of E237G and -109 C/T polymorphisms

Association of RsaI_in2, RsaI_ex7, and I181L polymorphisms in asthma and/or allergic rhinitis risk

For these three polymorphisms, three studies that focused on the association of RsaI_in2 polymorphisms and allergic diseases risk involving 274 cases and 217 controls, two studies that focused on the association between RsaI_ex7 polymorphisms and allergic diseases risk involving 177 cases and 130 controls, and two studies that focused on the association of I181L polymorphisms and allergic diseases risk involving 290 cases and 150 controls were pooled into the meta-analysis. No significant association was found for RsaI_in2 and RsaI_ex7 polymorphisms in all genetic models. For I181L polymorphism, significant association with increased allergic diseases risk was also observed in B vs. A (OR = 2.00, 95%CI = 1.35-2.97), AB+BB vs. AA (OR = 4.19, 95%CI = 2.35-7.47) and AB vs. AA (OR = 4.15, 95%CI = 2.33-7.41) genetic models.

Sensitivity analysis and publication bias

We omitted each particular study to verify whether our results were influenced by each individual study or not. The pooled ORs were not materially altered, indicating the robustness and stable of the results in this meta-analysis (Figure 6). The Begg’s funnel plot and Egger’s test were used to evaluate the publication bias (Table 4). All the plots were found to be roughly symmetrical, indicating no publication bias presented as shown in Figure 7.

Figure 6
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6 Sensitivity analysis through the deletion of each study to reflect the individual influence on the calculated ORs in allelic genetic model of E237G polymorphism
Figure 7
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7 Funnel plot analysis to detect publication bias for allelic genetic model of E237G polymorphism

The weight of studies is presented by the size of circles.

View this table:
  • View inline
  • View popup
Table 4 Evaluation of the publication bias of E237G and -109 C/T polymorphisms of the included studies

Discussion

In the last decade, analysis of SNPs has become the newest approach for detection and localization of the genetic determinants of asthma [63–66]. Genetic factors are important in defining total serum IgE levels. Linkage analyses have localized a gene or genes that influence atopic phenotype at chromosome 11q13 [34–36]. In this meta-analysis, we discussed five polymorphisms in FcεRIβ (E237G, -109 C/T, RsaI_in2, RsaI_ex7, and I181L) which were considered to have certain correlation to allergic diseases by pooled results from 29 eligible case–control studies. Only two extensively investigated SNPs (E237G and -109 C/T) were involving large sample of studies included this meta-analysis. Other SNPs (RsaI_in2, RsaI_ex7, and I181L) had limited number of studies, especially for V183L, we failed to collect enough studies and data to comprehensively analyze the risk for allergic diseases.

The results demonstrated that FcεRIβ E237G polymorphism in allelic model acts as significant increased risk for asthma, especially in Asians, which is consistent with previous results [66,67]. The stratification on allergic status and ethnicity did reveal a statistically significant association for E237G and the risk of allergic diseases. With respect to FcεRIβ -109 C/T polymorphism, a significantly association was observed in recessive genetic model, it has been demonstrated that -109 C/T polymorphism may play an important role in pathophysiologic mechanisms and the subgroup analysis by allergic status and ethnicity also showed the increased risk for allergic diseases, which validated the previous speculation [67]. For I181L polymorphism, significant association with increased allergic diseases risk was also observed in three genetic models, given the limited number of studies, more data are required to validate these associations.

Heterogeneity is one of the most important problems when performing the meta-analysis. The results should be interpreted with caution when heterogeneity exists. There was high heterogeneity in this meta-analysis. Considering that differences in allergic status, ethnicity and WHE may affect the results, we conducted subgroup analysis by allergic status, ethnicities and WHE, the heterogeneity was decreased or removed after subgroup analysis; however, there still existed or increased in some groups, perhaps, the source of heterogeneity may be from different ages or other clinical characteristics such as sex and environmental exposures, unfortunately, there were no enough data to extract to analyze.

Although this is not the first meta-analysis focused on the association between FcεRIβ polymorphisms and allergic diseases, there were some strengths of our study: first, most of the genotype distributions in controls were consistent with HWE. Second, the relationship was analyzed by using five kinds of genetic models, and the results were statistically significant. Third, the methodological issues for meta-analysis, such as Egger’s test, Begg’s funnel plots, and subgroup analysis were performed to ensure the stability of the results. On the other hand, the limitations could not be ignored: first, the interaction of gene–gene and gene–environment should be considered. Second, most of the included studies were conducted in Asian and Caucasian populations, although other ethnicities should be considered. Third, different genotyping methods were used in the respective studies, which might partly influence the result.

Conclusions

In conclusions, it is believed that subjects with FcεRIβ polymorphisms tend to develop allergic diseases, severity of symptoms caused by genetic variation could independently modify predisposition to allergic diseases. A greater understanding of the genetic basis of asthma and allergic rhinitis holds great promise for the identification of novel therapeutic targets. Further multicentric investigations still need to confirm the relationship of these polymorphisms of FcεRIβ and allergic diseases susceptibility.

Author Contribution

H.H.G. and X.H.Z. conceived and designed the study. H.H.G. and P.L. searched the databases and extracted the data. T.P. and H.B.L. analyzed the data. H.H.G., S.H., and S.L. wrote the draft of the paper. X.H.Z. and W.D.Z. reviewed and revised the manuscript. All the authors approved the final manuscript.

Funding

The authors declare that there are no sources of funding to be acknowledged.

Competing Interests

The authors declare that there are no competing interests associated with the manuscript.

Abbreviations: AR, allergic rhinitis; CI, confidence interval; HWE, hardy–weinberg equilibrium; NOS, newcastle–ottawa scale; OR, odd ratio; SNP, single nucleotide polymorphism

  • © 2018 The Author(s).
http://creativecommons.org/licenses/by/4.0/

This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).

References

  1. ↵
    1. Kakli H.A.,
    2. Riley T.D.
    (2016) Allergic rhinitis. Prim. Care 43, 465–475 doi:10.1016/j.pop.2016.04.009 pmid:27545735
    OpenUrlCrossRefPubMed
  2. ↵
    1. Accordini S.,
    2. Corsico A.,
    3. Cerveri I.,
    4. Gislason D.,
    5. Gulsvik A.,
    6. Janson C.,
    (2008) The socio-economic burden of asthma is substantial in Europe. Allergy 63, 116–124 doi:10.1111/j.1398-9995.2007.01523.x pmid:18053021
    OpenUrlCrossRefPubMed
  3. ↵
    1. Tattersfield A.E.,
    2. Knox A.J.,
    3. Britton J.R.,
    4. Hall I.P.
    (2002) Asthma. Lancet 360, 1313–1322 doi:10.1016/S0140-6736(02)11312-2 pmid:12414223
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Bochner B.S.,
    2. Busse W.W.
    (2005) Allergy and asthma. J. Allergy Clin. Immunol. 115, 953–959 doi:10.1016/j.jaci.2005.02.032 pmid:15867851
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Sengler C.,
    2. Lau S.,
    3. Wahn U.,
    4. Nickel R.
    (2002) Interactions between genes and environmental factors in asthma and atopy: new developments. Respir. Res. 3, 7 doi:10.1186/rr179 pmid:11806842
    OpenUrlCrossRefPubMed
  6. ↵
    1. Kauffmann F.,
    2. Demenais F.
    (2012) Gene-environment interactions in asthma and allergic diseases: challenges and perspectives. J. Allergy Clin. Immunol. 130, 1229–1240, quiz 1241-1222 doi:10.1016/j.jaci.2012.10.038 pmid:23195523
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Los H.,
    2. Koppelman G.H.,
    3. Postma D.S.
    (1999) The importance of genetic influences in asthma. Eur. Respir. J. 14, 1210–1227 doi:10.1183/09031936.99.14512109 pmid:10596715
    OpenUrlAbstract
  8. ↵
    1. van Beijsterveldt C.E.,
    2. Boomsma D.I.
    (2007) Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins. Eur. Respir. J. 29, 516–521 doi:10.1183/09031936.00065706 pmid:17215318
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Andiappan A.K.,
    2. Wang de Y.,
    3. Anantharaman R.,
    4. Suri B.K.,
    5. Lee B.T.,
    6. Rotzschke O.,
    (2013) Replication of genome-wide association study loci for allergic rhinitis and house dust mite sensitization in an Asian population of ethnic Chinese in Singapore. J. Allergy Clin. Immunol. 131, 1431.e1438–1433.e1438 doi:10.1016/j.jaci.2012.11.001
    OpenUrlCrossRef
  10. ↵
    1. Nilsson D.,
    2. Andiappan A.K.,
    3. Hallden C.,
    4. Tim C.F.,
    5. Sall T.,
    6. Wang de Y.,
    (2013) Poor reproducibility of allergic rhinitis SNP associations. PLoS One 8, e53975 doi:10.1371/journal.pone.0053975 pmid:23382861
    OpenUrlCrossRefPubMed
  11. ↵
    1. Andiappan A.K.,
    2. Nilsson D.,
    3. Hallden C.,
    4. Yun W.D.,
    5. Sall T.,
    6. Cardell L.O.,
    (2013) Investigating highly replicated asthma genes as candidate genes for allergic rhinitis. BMC Med. Genet. 14, 51 doi:10.1186/1471-2350-14-51 pmid:23663310
    OpenUrlCrossRefPubMed
  12. ↵
    1. Shirakawa T.,
    2. Mao X.Q.,
    3. Sasaki S.,
    4. Enomoto T.,
    5. Kawai M.,
    6. Morimoto K.,
    (1996) Association between atopic asthma and a coding variant of Fc epsilon RI beta in a Japanese population. Hum. Mol. Genet. 5, 2068 pmid:8968765
    OpenUrlPubMedWeb of Science
  13. ↵
    1. Hizawa N.,
    2. Yamaguchi E.,
    3. Jinushi E.,
    4. Kawakami Y.
    (2000) A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population. Am. J. Respir. Crit. Care Med. 161, 906–909 doi:10.1164/ajrccm.161.3.9903128 pmid:10712341
    OpenUrlCrossRefPubMed
  14. ↵
    1. Laprise C.,
    2. Boulet L.P.,
    3. Morissette J.,
    4. Winstall E.,
    5. Raymond V.
    (2000) Evidence for association and linkage between atopy, airway hyper-responsiveness, and the beta subunit Glu237Gly variant of the high-affinity receptor for immunoglobulin E in the French-Canadian population. Immunogenetics 51, 695–702 doi:10.1007/s002510000185 pmid:10941841
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Nagata H.,
    2. Mutoh H.,
    3. Kumahara K.,
    4. Arimoto Y.,
    5. Tomemori T.,
    6. Sakurai D.,
    (2001) Association between nasal allergy and a coding variant of the Fc epsilon RI beta gene Glu237Gly in a Japanese population. Hum. Genet. 109, 262–266 doi:10.1007/s004390100561 pmid:11702205
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Leung T.F.,
    2. Tang N.L.,
    3. Chan I.H.,
    4. Li A.M.,
    5. Ha G.,
    6. Lam C.W.,
    (2002) Distribution in allele frequencies of predisposition-to-atopy genotypes in Chinese children. Pediatr. Pulmonol. 34, 419–424 doi:10.1002/ppul.10210 pmid:12422339
    OpenUrlCrossRefPubMed
  17. ↵
    1. Cui T.,
    2. Wang L.,
    3. Wu J.,
    4. Xie J.
    (2003) The association analysis of FcepsilonRIbeta with allergic asthma in a Chinese population. Chin. Med. J. 116, 1875–1878 pmid:14687477
    OpenUrlPubMed
  18. ↵
    1. Rigoli L.,
    2. Di Bella C.,
    3. Procopio V.,
    4. Barberio G.,
    5. Barberi I.,
    6. Caminiti L.,
    (2004) Molecular analysis of sequence variants in the Fc epsilon receptor I beta gene and IL-4 gene promoter in Italian atopic families. Allergy 59, 213–218 doi:10.1046/j.1398-9995.2003.00385.x pmid:14763936
    OpenUrlCrossRefPubMed
  19. ↵
    1. Wang J.Y.,
    2. Liou Y.H.,
    3. Wu Y.J.,
    4. Hsiao Y.H.,
    5. Wu L.S.
    (2009) An association study of 13 SNPs from seven candidate genes with pediatric asthma and a preliminary study for genetic testing by multiple variants in Taiwanese population. J. Clin. Immunol. 29, 205–209 doi:10.1007/s10875-008-9256-6 pmid:18931892
    OpenUrlCrossRefPubMed
  20. ↵
    1. Takabayashi A.,
    2. Ihara K.,
    3. Sasaki Y.,
    4. Suzuki Y.,
    5. Nishima S.,
    6. Izuhara K.,
    (2000) Childhood atopic asthma: positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene. Exp. Clin. Immunogenet. 17, 63–70 doi:10.1159/000019125 pmid:10810222
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Korzycka-Zaborowska B.,
    2. Hopkin J.M.,
    3. Gorski P.
    (2004) Genetic variants of FcepsilonRIbeta and Il-4 and atopy in a Polish population. Allergol. Immunopathol. 32, 53–58 pmid:15087090
    OpenUrlPubMed
  22. ↵
    1. Liu T.,
    2. Teng L.,
    3. Guan L.X.,
    4. Wu L.P.,
    5. Sun K.Y.
    (2006) Study on the E237G polymorphism of the FcεRI β gene with asthma. Chin. J. Prac. Intern. Med. 26, 1520–1522
    OpenUrl
  23. ↵
    1. Blank U.,
    2. Ra C.,
    3. Miller L.,
    4. White K.,
    5. Metzger H.,
    6. Kinet J.P.
    (1989) Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 337, 187–189 doi:10.1038/337187a0 pmid:2521376
    OpenUrlCrossRefPubMed
  24. ↵
    1. Dombrowicz D.,
    2. Lin S.,
    3. Flamand V.,
    4. Brini A.T.,
    5. Koller B.H.,
    6. Kinet J.P.
    (1998) Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 8, 517–529 doi:10.1016/S1074-7613(00)80556-7 pmid:9586641
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Lin S.,
    2. Cicala C.,
    3. Scharenberg A.M.,
    4. Kinet J.P.
    (1996) The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. Cell 85, 985–995 doi:10.1016/S0092-8674(00)81300-8 pmid:8674126
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Hiraoka S.,
    2. Furumoto Y.,
    3. Koseki H.,
    4. Takagaki Y.,
    5. Taniguchi M.,
    6. Okumura K.,
    (1999) Fc receptor beta subunit is required for full activation of mast cells through Fc receptor engagement. Int. Immunol. 11, 199–207 doi:10.1093/intimm/11.2.199 pmid:10069418
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Galli S.J.,
    2. Tsai M.
    (2010) Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 40, 1843–1851 doi:10.1002/eji.201040559 pmid:20583030
    OpenUrlCrossRefPubMed
  28. ↵
    1. Kim Y.K.,
    2. Oh S.Y.,
    3. Oh H.B.,
    4. Chun S.Y.,
    5. Cho S.H.,
    6. Koh Y.Y.,
    (2002) Coding single nucleotide polymorphism in the high-affinity immunoglobulin E receptor b chain (FcepsilonRI-beta) gene is associated with immunoglobulin E receptor-mediated histamine release from basophils. Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol. 32, 751–755 doi:10.1046/j.1365-2222.2002.01295.x
    OpenUrlCrossRef
  29. ↵
    1. Turner H.,
    2. Kinet J.P.
    (1999) Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 402, B24–B30 doi:10.1038/35037021 pmid:10586892
    OpenUrlCrossRefPubMed
  30. ↵
    1. Holgate S.T.
    (1999) Genetic and environmental interaction in allergy and asthma. J. Allergy Clin. Immunol. 104, 1139–1146 doi:10.1016/S0091-6749(99)70005-9 pmid:10588993
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Barnes K.C.
    (1999) Gene-environment and gene-gene interaction studies in the molecular genetic analysis of asthma and atopy. Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol. 29, 47–51
    OpenUrl
  32. ↵
    1. Howard T.D.,
    2. Meyers D.A.,
    3. Bleecker E.R.
    (2000) Mapping susceptibility genes for asthma and allergy. J. Allergy Clin. Immunol. 105, S477–S481 doi:10.1016/S0091-6749(00)90046-0 pmid:10669527
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Kraft S.,
    2. Rana S.,
    3. Jouvin M.H.,
    4. Kinet J.P.
    (2004) The role of the FcepsilonRI beta-chain in allergic diseases. Int. Arch. Allergy Immunol. 135, 62–72 doi:10.1159/000080231
    OpenUrlCrossRefPubMed
  34. ↵
    1. Simon Thomas N.,
    2. Wilkinson J.,
    3. Lonjou C.,
    4. Morton N.E.,
    5. Holgate S.T.
    (2000) Linkage analysis of markers on chromosome 11q13 with asthma and atopy in a United Kingdom population. Am. J. Respir. Crit. Care Med. 162, 1268–1272 doi:10.1164/ajrccm.162.4.9909078 pmid:11029329
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Cookson W.O.,
    2. Sharp P.A.,
    3. Faux J.A.,
    4. Hopkin J.M.
    (1989) Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1, 1292–1295 doi:10.1016/S0140-6736(89)92687-1 pmid:2566826
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Sandford A.J.,
    2. Shirakawa T.,
    3. Moffatt M.F.,
    4. Daniels S.E.,
    5. Ra C.,
    6. Faux J.A.,
    (1993) Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q. Lancet 341, 332–334 doi:10.1016/0140-6736(93)90136-5 pmid:8094113
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Collee J.M.,
    2. ten Kate L.P.,
    3. de Vries H.G.,
    4. Kliphuis J.W.,
    5. Bouman K.,
    6. Scheffer H.,
    (1993) Allele sharing on chromosome 11q13 in sibs with asthma and atopy. Lancet 342, 936 doi:10.1016/0140-6736(93)91988-X pmid:8105198
    OpenUrlCrossRefPubMed
  38. ↵
    1. Stang A.
    (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25, 603–605 doi:10.1007/s10654-010-9491-z pmid:20652370
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    1. Higgins J.P.,
    2. Thompson S.G.
    (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 doi:10.1002/sim.1186 pmid:12111919
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Mantel N.,
    2. Haenszel W.
    (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719–748 pmid:13655060
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Higgins J.P.,
    2. Thompson S.G.,
    3. Spiegelhalter D.J.
    (2009) A re-evaluation of random-effects meta-analysis. J. R. Stat. Soc. Series A 172, 137–159 doi:10.1111/j.1467-985X.2008.00552.x
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Begg C.B.,
    2. Mazumdar M.
    (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101 doi:10.2307/2533446 pmid:7786990
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    1. Song F.,
    2. Gilbody S.
    (1998) Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis. BMJ 316, 471 pmid:9492690
    OpenUrlPubMed
  44. ↵
    1. Chen H.,
    2. Chen Y.Z.,
    3. Hu L.P.,
    4. Fu J.,
    5. Zhang H.Q.,
    6. Ma Y.
    (2000) Study on the Fcε RI-β polymorphism and susceptibility of asthma in a Chinese population. Natl. Med. J. China. 80, 664–667, pmid:11798832
    OpenUrlPubMed
  45. ↵
    1. Zeng L.X.,
    2. Zhou S.L.,
    3. Kuang J.L.,
    4. Rao W.H.
    (2001) Study of Mutation of B Chain Gene E237G༌A High Affinity Receptor of lgE in Asthmatics. Acta Academiae Medicinae Jiangxi 41, 43–45
    OpenUrl
  46. ↵
    1. Tang Y.,
    2. Wu X.Q.,
    3. Liu X.Y.,
    4. Zeng Y.,
    5. Li Y.Q.,
    6. Wu Q.,
    (2003) Study on mutations of β-chain of high affinity IgE receptor gene in people of Han nationality in the south of China. Chin. J. Mod. Med. 13, 6–10
    OpenUrl
  47. ↵
    1. Cui T.P.,
    2. Jiang W.C.,
    3. Wang L.,
    4. Xie J.G.,
    5. Wu J.M.
    (2004) Association analysis of FcεRIβ gene with allergic asthma in Chinese. Chin. J. Pathophys. 20, 2049–2052
    OpenUrl
  48. ↵
    1. Gan X.,
    2. Kuang J.L.,
    3. Zou Y.Q.,
    4. Rao W.H.
    (2004) Study on the relationship between IgE high affinity receptor β-chain gene polymorphism and serum total IgE in patients with bronchial asthma. Chin. J. Tuberc. Respir. Dis. 27, 704–705
    OpenUrl
  49. ↵
    1. Zhao K.S.,
    2. Cheng H.J.,
    3. Qiao H.M.,
    4. Zhao F.X.,
    5. Sun M.Y.,
    6. Fu W.Y.
    (2004) Analysis of gene mutation for high affinity immunoglobulin E receptor chain in asthmatic children. J. Clin. Pediatr. 22, 794–797
    OpenUrl
  50. ↵
    1. Zhao K.S.,
    2. Lu J.R.,
    3. Wang Z.H.,
    4. Guo Y.,
    5. Yu L.Y.,
    6. Fu W.Y.
    (2004) Association between FcεRI-β gene promoter polymorphism and total serum IgE levels of asthma in children. Chin. J. Prac. Pediatr. 19 744–746
    OpenUrl
  51. ↵
    1. Zheng B.Q.,
    2. Wang G.L.,
    3. Yang S.,
    4. Lu Y.Q.,
    5. Liu R.J.,
    6. Li Y.
    (2012) Study of genetic susceptibility in 198 children with asthma. Chin. J. Contemp. Pediatr. 14, 811–814
    OpenUrl
  52. ↵
    1. Soriano J.B.,
    2. De Cid R Estivill X,
    3. Antó J.M.,
    4. Sunyer J.,
    5. Otero D.,
    6. Roca J.,
    (2000) Association study of proposed candidate genes/regions in a population of Spanish asthmatics. Eur. J. Epidemiol. 16, 745–750 doi:10.1023/A:1026758319621 pmid:11142503
    OpenUrlCrossRefPubMed
  53. ↵
    1. Zhang X.,
    2. Zhang W.,
    3. Qiu D.,
    4. Sandford A.,
    5. Tan W.C.
    (2004) The E237G polymorphism of the high-affinity IgE receptor beta chain and asthma. Annals Allergy Asthma Immunol.: Off. Publication Am. College Allergy, Asthma, & Immunol. 93, 499–503 doi:10.1016/S1081-1206(10)61419-6
    OpenUrlCrossRef
  54. ↵
    1. Hizawa N.,
    2. Maeda Y.,
    3. Konno S.,
    4. Fukui Y.,
    5. Takahashi D.,
    6. Nishimura M.
    (2006) Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility. Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol. 36, 872–876 doi:10.1111/j.1365-2222.2006.02413.x
    OpenUrlCrossRefPubMedWeb of Science
  55. ↵
    1. Kim E.S.,
    2. Kim S.H.,
    3. Kim K.W.,
    4. Park H.S.,
    5. Shin E.S.,
    6. Lee J.E.,
    (2009) Involvement of FcE >R1 beta gene polymorphisms in susceptibility to atopy in Korean children with asthma. Eur. J. Pediatr. 168, 1483–1490 doi:10.1007/s00431-009-0960-x pmid:19288130
    OpenUrlCrossRefPubMed
  56. ↵
    1. Li H.,
    2. Xiaoyan D.,
    3. Quanhua L.,
    4. Jie L.,
    5. Yixiao B.
    (2009) Single-nucleotide polymorphisms in genes predisposing to asthma in children of Chinese Han nationality. J. Investig. Allergol. Clin. Immunol. 19, 391–395
    OpenUrlPubMed
  57. ↵
    1. Sharma S.,
    2. Ghosh B.
    (2009) Promoter polymorphism in the MS4A2 gene and asthma in the Indian population. Int. Arch. Allergy Immunol. 149, 208–218 doi:10.1159/000199716
    OpenUrlCrossRefPubMed
  58. ↵
    1. Tikhonova V.,
    2. Voitovich A.,
    3. Korostovsev D.,
    4. Larionova V.
    (2010) The -109C>T Polymorphism of the Fcer1B Gene in Children with Asthma. Pediatr. Res. 68, 413–413 doi:10.1203/00006450-201011001-00821
    OpenUrlCrossRef
  59. ↵
    1. Dmitrieva-Zdorova E.V.,
    2. Voronko O.E.,
    3. Latysheva E.A.,
    4. Storozhakov G.I.,
    5. Archakov A.I.
    (2012) Analysis of polymorphisms in T(H)2-associated genes in Russian patients with atopic bronchial asthma. J. Investig. Allergol. Clin. Immunol. 22, 126–132
    OpenUrlPubMed
  60. ↵
    1. Ramphul K.,
    2. Lv J.,
    3. Hua L.,
    4. Liu Q.H.,
    5. Fang D.Z.,
    6. Ji R.X.,
    (2014) Single nucleotide polymorphisms predisposing to asthma in children of Mauritian Indian and Chinese Han ethnicity. Brazilian J. Med. Biological Res. = Revista brasileira de pesquisas medicas e biologicas 47, 394–397
    OpenUrl
  61. ↵
    1. Amo G.,
    2. Garcia-Menaya J.,
    3. Campo P.,
    4. Cordobes C.,
    5. Seron M.C.P.,
    6. Ayuso P.,
    (2016) A Nonsynonymous FCER1B SNP is associated with risk of developing allergic rhinitis and with IgE levels. Sci. Rep. 6, doi:10.1038/srep19724
    OpenUrlCrossRef
  62. ↵
    1. Hua L.,
    2. Zuo X.B.,
    3. Bao Y.X.,
    4. Liu Q.H.,
    5. Li J.Y.,
    6. Lv J.,
    (2016) Four-locus gene interaction between IL13, IL4, FCER1B, and ADRB2 for asthma in Chinese Han children. Pediatr. Pulmonol. 51, 364–371 doi:10.1002/ppul.23322 pmid:26613553
    OpenUrlCrossRefPubMed
  63. ↵
    1. Denham S.,
    2. Koppelman G.H.,
    3. Blakey J.,
    4. Wjst M.,
    5. Ferreira M.A.,
    6. Hall I.P.,
    (2008) Meta-analysis of genome-wide linkage studies of asthma and related traits. Respir. Res. 9, 38 doi:10.1186/1465-9921-9-38 pmid:18442398
    OpenUrlCrossRefPubMed
  64. ↵
    1. Nanavaty U.,
    2. Goldstein A.D.,
    3. Levine S.J.
    (2001) Polymorphisms in candidate asthma genes. Am. J. Med. Sci. 321, 11–16 doi:10.1097/00000441-200101000-00003 pmid:11202474
    OpenUrlCrossRefPubMedWeb of Science
  65. ↵
    1. Palmer L.J.,
    2. Cookson W.
    (2001) Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma. Respir. Res. 2, 102–112 doi:10.1186/rr45 pmid:11686872
    OpenUrlCrossRefPubMed
  66. ↵
    1. Li X.,
    2. Zhang Y.,
    3. Zhang J.,
    4. Xiao Y.,
    5. Huang J.,
    6. Tian C.,
    (2010) Asthma susceptible genes in Chinese population: a meta-analysis. Respir. Res. 11, 129 doi:10.1186/1465-9921-11-129 pmid:20868478
    OpenUrlCrossRefPubMed
  67. ↵
    1. Yang H.J.,
    2. Zheng L.,
    3. Zhang X.F.,
    4. Yang M.,
    5. Huang X.
    (2014) Association of the MS4A2 gene promoter C-109T or the 7th exon E237G polymorphisms with asthma risk: a meta-analysis. Clin. Biochem. 47, 605–611 doi:10.1016/j.clinbiochem.2014.01.022 pmid:24495860
    OpenUrlCrossRefPubMed
View Abstract
Previous ArticleNext Article
Back to top

August 2018

Volume: 38 Issue: 4

Bioscience Reports: 38 (4)
  • Table of Contents
  • About the Cover
  • Index by author

Actions

Email

Thank you for your interest in spreading the word about Bioscience Reports.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case–control studies
(Your Name) has forwarded a page to you from Bioscience Reports
(Your Name) thought you would like to see this page from the Bioscience Reports web site.
Share
Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case–control studies
Huanhuan Guo, Tao Peng, Ping Luo, Huabin Li, Shuo Huang, Shuang Li, Weidong Zhao, Xuhong Zhou
Bioscience Reports Aug 2018, 38 (4) BSR20180177; DOI: 10.1042/BSR20180177
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Facebook logo Mendeley logo
Citation Tools
Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case–control studies
Huanhuan Guo, Tao Peng, Ping Luo, Huabin Li, Shuo Huang, Shuang Li, Weidong Zhao, Xuhong Zhou
Bioscience Reports Aug 2018, 38 (4) BSR20180177; DOI: 10.1042/BSR20180177

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts

Please log in to add an alert for this article.

Request Permissions
Save to my folders

View Full PDF

 Open in Utopia Docs
  • Tweet Widget
  • Facebook Like

Jump To

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Conclusions
    • Author Contribution
    • Funding
    • Competing Interests
    • References
  • Figures
  • Info & Metrics
  • PDF

Keywords

allergic diseases
Genetic Model
FcεRIβ
Meta-analysis
polymorphism

Related Articles

Cited By...

  • Portland Press Homepage
  • Publish With Us
  • Advertising
  • Technical Support
  • Bioscience Reports
  • Biochemical Journal
  • Clinical Science
  • Neuronal Signaling
  • Essays in Biochemistry
  • Emerging Topics in Life Sciences
  • Biochemical Society Transactions
  • Biochemical Society Symposia
  • Cell Signalling Biology

Portland Press Limited
Charles Darwin House
12 Roger Street
London WC1N 2JU
Email: editorial@portlandpress.com

The Biochemical Society